好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Dimethylfumarate in Real-Life: Efficacy and Safety in a Monocentric Prospective Cohort of 156 Patients with MS
Multiple Sclerosis
(-)
060
Authors/Disclosures
Jennifer Aboab
PRESENTER
Jennifer Aboab, 8220 has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI.
Antoine Gueguen, MD (Fondation Oph. A. De Rothschild, Service De Neurologie) An immediate family member of Dr. Gueguen has received personal compensation for serving as an employee of ABBVIE. Dr. Gueguen has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for ALEXION. Dr. Gueguen has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Jonhson&Jonhson. Dr. Gueguen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Johnson&Johnson. The institution of Dr. Gueguen has received research support from BrainEver. The institution of Dr. Gueguen has received research support from Pixyl. The institution of Dr. Gueguen has received research support from Kalsiom. The institution of Dr. Gueguen has received research support from Ministére de la Santé, France.
No disclosure on file
Caroline Bensa Caroline Bensa has nothing to disclose.
Antoine Moulignier, MD (Foundation Rothschild) No disclosure on file
Olivier F. Gout, MD (Hôpital Fondation A de Rothschild) Dr. Gout has nothing to disclose.